Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

[An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].

Galovičová A, Lazúrová I, Petrášová D.

Vnitr Lek. 2012 Nov;58(11):825-9. Slovak.

PMID:
23256827
2.

Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.

Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group..

Diabetes Care. 2008 Jun;31(6):1165-9. doi: 10.2337/dc07-2306. Epub 2008 Mar 17.

PMID:
18346990
3.

Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.

Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, Sasaki H, Narita T, Ito S, Kakei M.

Endocr J. 2006 Dec;53(6):745-52. Epub 2006 Sep 12.

4.

Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function.

Komaba H, Igaki N, Goto S, Yokota K, Doi H, Takemoto T, Kohno M, Hirosue Y, Goto T.

Am J Nephrol. 2006;26(5):476-82. Epub 2006 Nov 7.

PMID:
17095862
5.

Serum adiponectin is increased in type 1 diabetic patients with nephropathy.

Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane study group..

Diabetes Care. 2005 Jun;28(6):1410-4.

PMID:
15920060
6.

Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy.

Saraheimo M, Forsblom C, Pettersson-Fernholm K, Flyvbjerg A, Groop PH, Frystyk J; FinnDiane Study Group..

Nephrol Dial Transplant. 2008 Mar;23(3):914-8. Epub 2007 Nov 14.

PMID:
18003664
7.

Incipient and overt diabetic nephropathy in African Americans with NIDDM.

Dasmahapatra A, Bale A, Raghuwanshi MP, Reddi A, Byrne W, Suarez S, Nash F, Varagiannis E, Skurnick JH.

Diabetes Care. 1994 Apr;17(4):297-304.

PMID:
8026285
8.

Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.

Aso Y, Suganuma R, Wakabayashi S, Hara K, Nakano T, Suetsugu M, Matsumoto S, Nakamachi T, Takebayashi K, Morita K, Inukai T.

Transl Res. 2009 Oct;154(4):175-82. doi: 10.1016/j.trsl.2009.07.005. Epub 2009 Aug 3.

PMID:
19766961
9.

Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort.

Prior SL, Tang TS, Gill GV, Bain SC, Stephens JW.

Metabolism. 2011 Feb;60(2):173-9. doi: 10.1016/j.metabol.2009.12.008. Epub 2010 Feb 25.

PMID:
20188385
10.

Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.

Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O.

Nephrol Dial Transplant. 2004 Nov;19(11):2784-8. Epub 2004 Aug 24.

PMID:
15328385
11.

Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.

Mormile A, Veglio M, Gruden G, Girotto M, Rossetto P, D'Este P, Cavallo-Perin P.

Acta Diabetol. 1996 Sep;33(3):241-5.

PMID:
8904933
12.

[Clinical features and risk factors of renal damage in elderly and non-elderly patients with type 2 diabetes mellitus].

Huang H, Li H, Zheng FP, Lu WN, Dong XH, Ruan Y.

Zhonghua Yi Xue Za Zhi. 2010 Apr 13;90(14):967-71. Chinese.

PMID:
20646646
14.

Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.

Nannipieri M, Penno G, Rizzo L, Pucci L, Bandinelli S, Mattei P, Taddei S, Salvetti A, Navalesi R.

Diabetes Care. 1997 Jun;20(6):1019-26.

PMID:
9167118
15.

Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.

Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A.

Diabetes. 2000 Jul;49(7):1258-63.

PMID:
10909986
16.

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients.

Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M; International Diabetic Nephopathy Study Group..

Diabetes. 2005 Jul;54(7):2164-71.

17.

Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.

Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.

J Diabetes Complications. 2008 Nov-Dec;22(6):384-8. doi: 10.1016/j.jdiacomp.2007.07.004. Epub 2008 Apr 16.

PMID:
18413152
18.

Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.

Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A.

Nephrol Dial Transplant. 1996 Mar;11(3):449-56.

PMID:
8671814
19.

Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association.

Wolf G, Müller N, Busch M, Eidner G, Kloos C, Hunger-Battefeld W, Müller UA.

Nephrol Dial Transplant. 2009 Jun;24(6):1896-901. doi: 10.1093/ndt/gfn724. Epub 2009 Jan 7.

PMID:
19131351
20.

Proximal tubular reabsorption of growth hormone and sodium/fluid in normo- and microalbuminuric insulin-dependent diabetes mellitus.

Turner G, Coates P, Warren S, Woodhead JS, Peters JR.

Acta Diabetol. 1997 Mar;34(1):27-32.

PMID:
9134054

Supplemental Content

Support Center